The post NVIDIA’s OpenFold3 NIM: Advancing Biomolecular Structure Prediction appeared on BitcoinEthereumNews.com. Zach Anderson Nov 04, 2025 20:41 NVIDIA introduces OpenFold3 NIM, a transformative AI tool for biomolecular structure prediction, offering enhanced speed and accuracy for biopharma and biotech industries. NVIDIA has unveiled an innovative AI-driven tool, OpenFold3 NIM, designed to revolutionize the prediction of biomolecular structures, according to the NVIDIA Developer Blog. This advancement marks a significant milestone in the field of proteomics, where understanding how amino acids fold into complex structures is crucial for scientific progress. Transforming Structure Prediction The OpenFold3 NIM, developed by the OpenFold Consortium and accelerated by NVIDIA, extends its capabilities beyond single proteins to include multi-chain complexes, nucleic acids, and small-molecule ligands. This development is part of a broader trend where deep learning has begun to decode the intricate language of evolution, transforming structure prediction from a theoretical art into a practical engineering discipline. Technological Advancements The integration of NVIDIA’s cuEquivariance for GPU acceleration, compatibility with MMseqs2-GPU for fast sequence searches, and the federated training capabilities of NVIDIA FLARE, empowers OpenFold3 to deliver unprecedented performance. This tool is now available as an NVIDIA NIM, offering additional acceleration and making it accessible for biopharma and biotech teams globally. Practical Applications and Deployment OpenFold3 NIM facilitates rapid deployment, allowing users to move from prototype to production efficiently. It supports interaction through standard REST calls or Python clients, providing predictions that include 3D coordinates and confidence metrics. The tool is optimized for NVIDIA H100 Tensor Core GPUs, ensuring rapid and reliable results. Open Science and Enterprise Reliability The OpenFold Consortium, which includes major industry players like Bayer and Johnson & Johnson, has played a pivotal role in advancing open, reproducible modeling systems. OpenFold3 achieves performance parity with AlphaFold3 on protein-nucleic acid benchmarks, showcasing its accuracy and reliability. Classified as a Class… The post NVIDIA’s OpenFold3 NIM: Advancing Biomolecular Structure Prediction appeared on BitcoinEthereumNews.com. Zach Anderson Nov 04, 2025 20:41 NVIDIA introduces OpenFold3 NIM, a transformative AI tool for biomolecular structure prediction, offering enhanced speed and accuracy for biopharma and biotech industries. NVIDIA has unveiled an innovative AI-driven tool, OpenFold3 NIM, designed to revolutionize the prediction of biomolecular structures, according to the NVIDIA Developer Blog. This advancement marks a significant milestone in the field of proteomics, where understanding how amino acids fold into complex structures is crucial for scientific progress. Transforming Structure Prediction The OpenFold3 NIM, developed by the OpenFold Consortium and accelerated by NVIDIA, extends its capabilities beyond single proteins to include multi-chain complexes, nucleic acids, and small-molecule ligands. This development is part of a broader trend where deep learning has begun to decode the intricate language of evolution, transforming structure prediction from a theoretical art into a practical engineering discipline. Technological Advancements The integration of NVIDIA’s cuEquivariance for GPU acceleration, compatibility with MMseqs2-GPU for fast sequence searches, and the federated training capabilities of NVIDIA FLARE, empowers OpenFold3 to deliver unprecedented performance. This tool is now available as an NVIDIA NIM, offering additional acceleration and making it accessible for biopharma and biotech teams globally. Practical Applications and Deployment OpenFold3 NIM facilitates rapid deployment, allowing users to move from prototype to production efficiently. It supports interaction through standard REST calls or Python clients, providing predictions that include 3D coordinates and confidence metrics. The tool is optimized for NVIDIA H100 Tensor Core GPUs, ensuring rapid and reliable results. Open Science and Enterprise Reliability The OpenFold Consortium, which includes major industry players like Bayer and Johnson & Johnson, has played a pivotal role in advancing open, reproducible modeling systems. OpenFold3 achieves performance parity with AlphaFold3 on protein-nucleic acid benchmarks, showcasing its accuracy and reliability. Classified as a Class…

NVIDIA’s OpenFold3 NIM: Advancing Biomolecular Structure Prediction



Zach Anderson
Nov 04, 2025 20:41

NVIDIA introduces OpenFold3 NIM, a transformative AI tool for biomolecular structure prediction, offering enhanced speed and accuracy for biopharma and biotech industries.

NVIDIA has unveiled an innovative AI-driven tool, OpenFold3 NIM, designed to revolutionize the prediction of biomolecular structures, according to the NVIDIA Developer Blog. This advancement marks a significant milestone in the field of proteomics, where understanding how amino acids fold into complex structures is crucial for scientific progress.

Transforming Structure Prediction

The OpenFold3 NIM, developed by the OpenFold Consortium and accelerated by NVIDIA, extends its capabilities beyond single proteins to include multi-chain complexes, nucleic acids, and small-molecule ligands. This development is part of a broader trend where deep learning has begun to decode the intricate language of evolution, transforming structure prediction from a theoretical art into a practical engineering discipline.

Technological Advancements

The integration of NVIDIA’s cuEquivariance for GPU acceleration, compatibility with MMseqs2-GPU for fast sequence searches, and the federated training capabilities of NVIDIA FLARE, empowers OpenFold3 to deliver unprecedented performance. This tool is now available as an NVIDIA NIM, offering additional acceleration and making it accessible for biopharma and biotech teams globally.

Practical Applications and Deployment

OpenFold3 NIM facilitates rapid deployment, allowing users to move from prototype to production efficiently. It supports interaction through standard REST calls or Python clients, providing predictions that include 3D coordinates and confidence metrics. The tool is optimized for NVIDIA H100 Tensor Core GPUs, ensuring rapid and reliable results.

Open Science and Enterprise Reliability

The OpenFold Consortium, which includes major industry players like Bayer and Johnson & Johnson, has played a pivotal role in advancing open, reproducible modeling systems. OpenFold3 achieves performance parity with AlphaFold3 on protein-nucleic acid benchmarks, showcasing its accuracy and reliability. Classified as a Class 1 open-source system, it ensures transparency and reproducibility.

Federated Learning and Global Collaboration

OpenFold3 has proven its capability to scale across global R&D environments through secure federated workflows validated by Apheris and SandboxAQ. This allows partners to fine-tune models on proprietary data without sharing sensitive datasets, maintaining regulatory compliance while enhancing model performance with diverse datasets.

The Future of Protein AI

OpenFold3 represents more than just a technological advancement; it is a foundation for future developments in protein AI. By converging open-source science, accelerated computing, and federated collaboration, it ensures that the tools used by global researchers meet enterprise standards for reliability and security.

Image source: Shutterstock

Source: https://blockchain.news/news/nvidia-openfold3-nim-advancing-biomolecular-prediction

Market Opportunity
Nimiq Logo
Nimiq Price(NIM)
$0.000625
$0.000625$0.000625
-2.03%
USD
Nimiq (NIM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

The post Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now? appeared on BitcoinEthereumNews.com. On the lookout for a Sector – Tech fund? Starting with Putnam Global Technology A (PGTAX – Free Report) should not be a possibility at this time. PGTAX possesses a Zacks Mutual Fund Rank of 4 (Sell), which is based on various forecasting factors like size, cost, and past performance. Objective We note that PGTAX is a Sector – Tech option, and this area is loaded with many options. Found in a wide number of industries such as semiconductors, software, internet, and networking, tech companies are everywhere. Thus, Sector – Tech mutual funds that invest in technology let investors own a stake in a notoriously volatile sector, but with a much more diversified approach. History of fund/manager Putnam Funds is based in Canton, MA, and is the manager of PGTAX. The Putnam Global Technology A made its debut in January of 2009 and PGTAX has managed to accumulate roughly $650.01 million in assets, as of the most recently available information. The fund is currently managed by Di Yao who has been in charge of the fund since December of 2012. Performance Obviously, what investors are looking for in these funds is strong performance relative to their peers. PGTAX has a 5-year annualized total return of 14.46%, and is in the middle third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 27.02%, which places it in the middle third during this time-frame. It is important to note that the product’s returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund’s [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund’s performance, it…
Share
BitcoinEthereumNews2025/09/18 04:05
US regulators move toward unified crypto oversight as sec project crypto gains CFTC support

US regulators move toward unified crypto oversight as sec project crypto gains CFTC support

SEC PROJECT CRYPTO signals a shift as US regulators align SEC and CFTC oversight toward clearer rules for digital assets and markets.
Share
The Cryptonomist2026/01/30 19:21
SoFi Stock Jumps as Fintech Tops $1 Billion in Quarterly Revenue for First Time

SoFi Stock Jumps as Fintech Tops $1 Billion in Quarterly Revenue for First Time

TLDR SoFi Technologies reported fourth-quarter revenue of $1.01 billion, up 37% year-over-year, marking the first time quarterly revenue exceeded $1 billion The
Share
Blockonomi2026/01/30 21:23